SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Tilray Brands, Inc. engages as a consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis, Distribution, Beverage, and Wellness. The Cannabis segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage segment refers to the production, marketing, and sale of beverages. The Wellness segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Tilray Brands Inc

TLRY is trending as the cannabis sector is gaining momentum amid discussions of potential federal policy changes, including reclassification of marijuana. The community is closely watching for announcements from the Trump administration and the Supreme Court, anticipating a short squeeze. Positive news around Redecan's new product launch is also contributing to the bullish sentiment.

Broadcom Inc. is a global technology company, which designs, develops, and supplies semiconductors and infrastructure software solutions. It operates through the Semiconductor Solutions and Infrastructure Software segments. The Semiconductor Solutions segment refers to product lines and intellectual property licensing. The Infrastructure Software segment relates to mainframe, distributed and cyber security solutions, and the FC SAN business. The company was founded in 1961 and is headquartered in Palo Alto, CA.

Broadcom Inc

Broadcom ($AVGO) is experiencing volatility following earnings, initially jumping on strong AI chip demand and guidance, but then declining due to profit-taking and concerns about non-AI revenue. The community is actively debating whether the pullback is a buying opportunity or a sign of an overvalued stock, with some pointing to potential gross margin compression and dependence on OpenAI revenue as causes for concern. Despite the mixed sentiment, underlying AI demand remains a key talking point, with analysts weighing in on future target prices.

A project grown out of the community's love and passion for the weed culture. Launched around early 2025, $weedcoin, “Like Bitcoin but way higher,” emphasizes its alignment with cannabis culture and a laid-back vibe. Unlike other Weed communities, this project leans heavily into community engagement over technical utility, aiming to build a “stoner community” through social media presence and decentralized governance. We also aim to focus on onboarding web2 businesses and users onto web3 through the token.

Weedcoin

Weedcoin is gaining traction as discussions around cannabis reform intensify, with community members highlighting its potential role in the cultural shift. The project, built on Solana, is described as a culture coin with a focus on long-term growth and a strong community vibe. Some users are drawing parallels to Bitcoin, emphasizing Weedcoin's potential within the cannabis culture.

Altimmune, Inc. is a clinical stage biopharmaceutical company, which focuses on the development of novel peptide-based therapeutics for the treatment of obesity and liver diseases. The company's lead product candidate, pemvidutide, is a GLP-1/glucagon dual receptor agonist that is being developed for the treatment of obesity and NASH. In addition, Altimmune is developing HepTcell, an immunotherapeutic designed to achieve a functional cure for chronic hepatitis B. The company was founded in 1997 and is headquartered in Gaithersburg, MD.

Altimmune Inc

Altimmune is trending as investors anticipate upcoming catalysts, including 48-week data and an FDA meeting, while closely monitoring the competitive landscape of MASH and obesity treatments. Community members are debating the potential impact of these events, with some expressing concerns about trial endpoints and others highlighting the company's leadership changes as a signal for a potential partnership or buyout. Discussions also revolve around efforts to manage expectations, counter misinformation, and interpret technical indicators amidst mixed opinions on the stock's near-term prospects.

Advanced Micro Devices, Inc. engages in the provision of semiconductor businesses. It operates through the following segments: Data Center, Client, Gaming, and Embedded. The Data Center segment includes server-class CPUs, GPUs, AI accelerators, DPUs, FPGAs, SmartNICs, and Adaptive SoC products. The Client segment refers to the computing platforms, which are a collection of technologies that are designed to work together to provide a more complete computing solution. The Gaming segment is a fundamental component across many products and can be found in APU, GPU, SoC or a combination of a discrete GPU with another product working in tandem. The Embedded segment focuses on the embedded CPUs, GPUs, APUs, FPGAs, and Adaptive SoC products. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMD is trending as investors digest the potential impacts of both competitor Broadcom's earnings and news regarding AI chip exports to China. The community is actively discussing AMD's valuation, potential catalysts, and technical indicators for possible breakouts, with some focusing on long-term growth prospects. Some traders are also pointing to the potential of an island reversal.

lululemon athletica, Inc. engages in the business of designing, distributing, and retailing technical athletic apparel, footwear, and accessories. It operates through the following segments: Company-Operated Stores, Direct to Consumer, and Other. The company was founded by Dennis James Wilson in 1998 and is headquartered in Vancouver, Canada.

Lululemon Athletica inc.

Lululemon Athletica Inc

Lululemon is trending following a Q3 earnings beat, raised full-year guidance, and a significant buyback announcement, coupled with news of CEO succession plans. Community members are weighing in on the company's growth trajectory, potential analyst upgrades, and the impact of international sales, especially in China. Some traders are noting the potential for a short squeeze, while others are discussing the impact of leadership changes.

Mawson Infrastructure Group, Inc. engages in the provision of digital asset infrastructure services. The company was founded on February 10, 2012 and is headquartered in Midland, PA.

Mawson Infrastructure Group Inc

MIGI is trending amidst high volatility and a wide range of community perspectives, with some traders citing the stock's low float and potential for a squeeze. Discussions revolve around a recent surge in price followed by a sharp decline, leaving investors debating whether to hold for a potential rebound or exit. The conversation also includes speculation about upcoming announcements, and potential catalysts.

Costco Wholesale Corp. engages in the provision of operation of membership warehouses through wholly owned subsidiaries. It operates through the following geographical segments: United States, Canada, and Other International Operations. The company was founded by James D. Sinegal and Jeffrey H. Brotman in 1983 and is headquartered in Issaquah, WA.

Costco Wholesale Corp

Costco's stock is trending as investors digest recent earnings and sales data, with community discussions focusing on whether the numbers justify the stock's valuation. While some highlight the company's strong membership model and digital growth, others point to a potential slowdown in membership growth and question the high P/E ratio compared to competitors. The community is also watching for any news on a potential special dividend or stock split, as well as the impact of an ongoing lawsuit regarding tariff refunds.

Shopify, Inc. is a global commerce company that provides essential internet infrastructure for commerce, offering trusted tools to start, scale, market, and run a retail business of any size. The Company's software enables merchants to run their business across all of their sales channels, including web and mobile storefronts, physical retail locations, social media storefronts and marketplaces. The Shopify platform provides merchants with a single view of their business across all of their sales channels and enables them to manage products and inventory, process orders and payments, fulfill and ship orders, build customer relationships, source products, leverage analytics and reporting and access financing, all from one integrated back office. The company was founded on September 28, 2004 and is headquartered in Ottawa, Canada.

Shopify Inc - Ordinary Shares - Class A (Sub Voting)

Shopify Inc

Direxion Shares ETF Trust - Direxion Daily S&P 500 Bear -3X Shares

Direxion Daily S&P 500 Bear 3X Shares

SPXS is trending as traders assess potential market downside, with some citing technical indicators and economic concerns. Community members discuss entry points, swing trading strategies, and hedging long positions, reflecting uncertainty about the market's direction. The potential impact of geopolitical events and upcoming economic data on SPXS and the broader market is also being actively debated.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Neuphoria Therapeutics, Inc. is a clinical-stage biotechnology company dedicated to developing therapies that address the complex needs of individuals affected by neuropsychiatric disorders. It focuses on developing BNC210, an oral drug designed for the acute treatment of social anxiety disorder (SAD) and the chronic treatment of post-traumatic stress disorder (PTSD) by selectively targeting the a7 nicotinic acetylcholine receptor. The company was founded on December 23, 2024 and is headquartered in Burlington, MA.

Neuphoria Therapeutics Inc.

Bullish: S&P grinds higher

Choppy but up: buy dips

Sideways: fade the move

Bearish: this rally falls off

The Federal Reserve just announced a 0.25 percentage point interest rate cut at its December 10, 2025 meeting.​ Share your outlook on how the latest Federal Reserve interest rate cut will impact stocks and the S&P 500 over the next month.

How do you think today’s Fed rate cut impacts stocks over the next month?

Current Price	$3.98
Prev Close	$4.21
Open	$4.28
Dividend Yield	0.00%
50-Day Moving Average	$7.82
Beta	1.00
Avg. Volume	190,764.74
PE Ratio	-0.17

52-Week High	$21.40
52-Week Low	$2.77
Market Capitalization	$22.64M
EPS (Annual)	-$0.2278
Price to Book	0.75
Revenue Per Employee	$1.96M
Enterprise Value/EBITDA	N/A

BNOX
Bionomics ADS

Feed

News

Sentiment

Fundamentals

Info

Latest BNOX News

BNOXBionomics ADS